
Insulet earns insulin patch pump patent victory against EOFlow with permanent injunction
The Insulet Omnipod 5 (left) and the EOFlow EOPatch (right). [Images courtesy of the companies]Insulet (Nasdaq: PODD) + had the court rule in its favor again in its IP battle with Korea-based insulin patch pump maker EOFlow. Our sister site, Drug Delivery …